Advertisement

Topics

"Adalimumab biosimilar Idacio launched Germany" Drugs and Medication Database

11:03 EDT 20th June 2019 | BioPortfolio

Here are the most relevant "Adalimumab biosimilar Idacio launched Germany" Drugs and Medications that we have found in our database.

More Information about "Adalimumab biosimilar Idacio launched Germany" on BioPortfolio

We have published hundreds of Adalimumab biosimilar Idacio launched Germany news stories on BioPortfolio along with dozens of Adalimumab biosimilar Idacio launched Germany Clinical Trials and PubMed Articles about Adalimumab biosimilar Idacio launched Germany for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Adalimumab biosimilar Idacio launched Germany Companies in our database. You can also find out about relevant Adalimumab biosimilar Idacio launched Germany Drugs and Medications on this site too.

Showing "Adalimumab biosimilar Idacio launched Germany" Drugs and Medications, all 10

Possibly Relevant

Imraldi [samsung bioepis co., ltd.]

These highlights do not include all the information needed to use IMRALDI safely and effectively. See full prescribing information for IMRALDI.IMRALDI (adalimumab-xxxx) injection, for subcutaneous useInitial U.S. Approval: YYYY IMRALDI (adalimumab-xxxx) i

Sterile water [genentech, inc.]

Sterile Water for Injection, USP

Oxygen [airway oxygen, inc.]

oxygen

Oxygen [metro aire ltd]

Oxygen

Humira [a-s medication solutions]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002

Humira [abbvie inc.]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002

Mvasi [amgen inc]

These highlights do not include all the information needed to use MVASI safely and effectively. See full prescribing information for MVASI .     MVASI (bevacizumab-awwb ) Solution for intravenous infusion Initial U.S. Approval: 2017 MVASI (bevacizumab-

Tremfya [janssen biotech, inc.]

These highlights do not include all the information needed to use TREMFYA safely and effectively. See full prescribing information for TREMFYA. TREMFYA (guselkumab) injection, for subcutaneous use Initial U.S. Approval: 2017

Isopto atropine [alcon laboratories, inc.]

These highlights do not include all the information needed to use ISOPTO® ATROPINE safely and effectively. See full prescribing information for ISOPTO® ATROPINE ISOPTO® ATROPINE (atropine sulfate ophthalmic solution) 1%, for topical  ophthalmic useIni

Rotop - dmsa [rotop pharmaka gmbh]

ROTOP – DMSA



Advertisement
Quick Search
Advertisement
Advertisement